Claudio Nicotra
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 19
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 2
-
- Lung Cancer Treatments and Mutations 12
- Lung Cancer Diagnosis and Treatment 3
-
- Bladder and Urothelial Cancer Treatments 3
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
-
- Radiomics and Machine Learning in Medical Imaging 6
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Ludovic LacroixBenjamin BesseJean‐Charles SoriaDavid PlanchardJordi RemónMaud Ngo‐CamusKaren HowarthThierry de Baère
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Claudio Nicotra
21 papers receiving 402 citations
Peers
Comparison fields: 5 of 41
- Cancer Research 205
- Oncology 245
- Pulmonary and Respiratory Medicine 242
- Pathology and Forensic Medicine 59
- Surgery 118
Countries citing papers authored by Claudio Nicotra
This map shows the geographic impact of Claudio Nicotra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Nicotra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Nicotra more than expected).
Fields of papers citing papers by Claudio Nicotra
This network shows the impact of papers produced by Claudio Nicotra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Nicotra. The network helps show where Claudio Nicotra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claudio Nicotra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 13 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 1 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 92 | |
| 11 | 2019 | 18 | |
| 12 | 2018 | 0 | |
| 13 | 2018 | 14 | |
| 14 | 2018 | 7 | |
| 15 | 2018 | 0 | |
| 16 | 2017 | 133 | |
| 17 | 2017 | 2 | |
| 18 | 2017 | 109 | |
| 19 | 2017 | 1 | |
| 20 | 2017 | 4 |
About Claudio Nicotra
Claudio Nicotra is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 407 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (19 papers), Lung Cancer Treatments and Mutations (12 papers), Radiomics and Machine Learning in Medical Imaging (6 papers), Bladder and Urothelial Cancer Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Cancer Research (205 citations), Oncology (245 citations) and Pulmonary and Respiratory Medicine (242 citations). Claudio Nicotra has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Ludovic Lacroix, Benjamin Besse, Jean‐Charles Soria, David Planchard, Jordi Remón, Maud Ngo‐Camus, Karen Howarth, Thierry de Baère, Antoine Hollebecque and Édouard Auclin. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.